EUVIMEDObjevte EUVIMED
Crossref

Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing

Wenxin Zhang, Shoufang Qu, Qiong Chen, Xuexi Yang, Jing Yu, Shuang Zeng, Yuxing Chu, Hao Zou, Zhihong Zhang, Xiaowen Wang, Ruilin Jing, Yingsong Wu and 5 more

Technology and Health Care · 2023

DOI: 10.3233/thc-220102 ↗

At a glance

Journal article in Technology and Health Care, 2023. Written by Wenxin Zhang and 16 co-authors. Institution: Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing, China. Major MEDLINE topics: Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras). 38 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: Along with the dramatic development of molecular diagnostic testing for the detection of oncogene variations, reference materials (RMs) have become increasingly important in performance evaluation of genetic testing. OBJECTIVE: In this study, we built a set of RMs for genetic testing based on next-generation sequencing (NGS). METHOD: Solid tumor tissues were selected as the samples of RMs for preparation. NGS was used to determine and validate the variants and the mutation frequency in DNA samples. Digital PCR was used to determine the copy numbers of RNA samples. The performance of the RMs was validated by six laboratories. RESULTS: Thirty common genetic alterations were designed based on these RMs. RMs consisted of a positive reference, a limit of detection reference, and a negative reference. The validation results confirmed the performance of the RMs. CONCLUSION: These RMs may be an attractive tool for the development, validation, and quality monitoring of molecular genetic testing.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)HumansClass I Phosphatidylinositol 3-KinasesErbB ReceptorsGenetic TestingGTP PhosphohydrolasesMembrane ProteinsMutationReceptor Protein-Tyrosine KinasesProto-Oncogene Proteins c-met

Author keywords

Reference materialsgenetic testingoncogene variantsquality control

Substances

Class I Phosphatidylinositol 3-KinasesErbB ReceptorsGTP PhosphohydrolasesMembrane ProteinsProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Receptor Protein-Tyrosine KinasesBRAF protein, humanEGFR protein, humanKRAS protein, human

Authors and institutions

  • Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing, China.
  • Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China.
  • Medical Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • BGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong, China.
  • Geneplus-Beijing Clinical Laboratory Co., Ltd., Beijing, China.
  • Novogene (Tianjin) Bioinformatics Technology Co., Ltd., Tianjin, China.

Cite

APA

Zhang, W., Qu, S., Chen, Q., Yang, X., Yu, J., Zeng, S., Chu, Y., Zou, H., Zhang, Z., Wang, X., Jing, R., Wu, Y., Liu, Z., Xu, R., Wu, C., Huang, C., & Huang, J. (2023). Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing. Technology and Health Care. https://doi.org/10.3233/thc-220102

Vancouver

Zhang W, Qu S, Chen Q, Yang X, Yu J, Zeng S, et al. Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing. Technology and Health Care. 2023. doi:10.3233/thc-220102

BibTeX
@article{Zhang2023,
  author = {Zhang, Wenxin and Qu, Shoufang and Chen, Qiong and Yang, Xuexi and Yu, Jing and Zeng, Shuang and Chu, Yuxing and Zou, Hao and Zhang, Zhihong and Wang, Xiaowen and Jing, Ruilin and Wu, Yingsong and Liu, Zhipeng and Xu, Ren and Wu, Chunyan and Huang, Chuanfeng and Huang, Jie},
  title = {Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing},
  journal = {Technology and Health Care},
  year = {2023},
  doi = {10.3233/thc-220102}
}
Start for free →